PepGen
PEPG • NASDAQ
PepGen is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James G. McArthur, with a market cap of $312.4M.
CEOJames G. McArthur
Next Earnings
Upcoming earnings announcement for PepGen
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.31
Earnings History
Past 12 earnings reports for PepGen
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Q4 2025 | -$0.27Est: -$0.40 | +32.5% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.52Est: -$0.55 | +5.5% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.70Est: -$0.83 | +15.7% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.92Est: -$0.75 | -22.7% | - | — | 10-Q |
| Feb 24, 2025 | Q4 2024 | -$0.68Est: -$0.72 | +5.6% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.66Est: -$0.87 | +24.1% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.87Est: -$0.72 | -20.8% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.63Est: -$0.74 | +14.9% | - | — | 10-Q |
| Mar 6, 2024 | Q4 2023 | -$0.81Est: -$1.01 | +19.8% | - | — | 10-K/A |
| Nov 8, 2023 | Q3 2023 | -$0.98Est: -$0.88 | -11.4% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.82Est: -$0.81 | -1.2% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.69Est: -$0.79 | +12.7% | - | — | — |